Stoke Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2022 | — | -841.2% | -814.7% |
| FY2023 | — | -1,307.2% | -1,192.5% |
| FY2024 | — | -277.3% | -243.4% |
| FY2025 | — | -11.2% | -3.7% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2022 | — | -841.2% | -814.7% |
| FY2023 | — | -1,307.2% | -1,192.5% |
| FY2024 | — | -277.3% | -243.4% |
| FY2025 | — | -11.2% | -3.7% |